European Pharmaceutical Preparations Turnover by Country

In 2024, Germany leads the European pharmaceutical preparations market with a turnover of €111.34 billion, followed by Switzerland at €87.21 billion, and Belgium at €47.74 billion. France and Italy exhibit significant disparities, with turnovers of €44.16 billion and €22.16 billion, respectively. Notable positive year-on-year variations include Belgium (12.64%), Portugal (12.14%), and Serbia (5.76%), whereas France (-0.36%) and Italy (-1.08%) show negative trends. Observing the compounded annual growth rate (CAGR) over the past five years, Germany and Switzerland have maintained robust growth, while Italy and France have faced stagnation or slight decline.

Future trends to watch in the European pharmaceutical preparations market include increased investment in biotechnology and precision medicine, a focus on sustainable and green pharmaceuticals, and the impact of regulatory changes. Additionally, digital transformation in healthcare and deeper integration of AI could significantly influence market dynamics. Countries with smaller turnovers like Romania and Croatia may also see accelerated growth as they adapt to technological advancements and attract more international collaborations.